Rtw Investments as of Dec. 31, 2015
Portfolio Holdings for Rtw Investments
Rtw Investments holds 29 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 17.8 | $54M | 573k | 94.14 | |
| La Jolla Pharmaceuticl Com Par | 9.7 | $29M | 1.1M | 27.00 | |
| Omeros Corporation (OMER) | 9.4 | $29M | 1.8M | 15.73 | |
| Kite Pharma | 8.5 | $26M | 419k | 61.62 | |
| Dicerna Pharmaceuticals | 7.9 | $24M | 2.0M | 11.87 | |
| Achillion Pharmaceuticals | 7.1 | $22M | 2.0M | 10.79 | |
| BioCryst Pharmaceuticals (BCRX) | 6.8 | $21M | 2.0M | 10.32 | |
| Mirati Therapeutics | 4.0 | $12M | 386k | 31.60 | |
| Atara Biotherapeutics (ATRA) | 3.8 | $12M | 434k | 26.41 | |
| Five Prime Therapeutics | 3.5 | $11M | 257k | 41.50 | |
| Agenus (AGEN) | 3.3 | $10M | 2.2M | 4.54 | |
| Celldex Therapeutics | 3.3 | $10M | 637k | 15.68 | |
| Symmetry Surgical | 2.7 | $8.1M | 880k | 9.20 | |
| Bristol Myers Squibb (BMY) | 2.5 | $7.5M | 110k | 68.79 | |
| Corium Intl | 2.0 | $6.0M | 744k | 8.12 | |
| Global Blood Therapeutics In | 1.9 | $5.7M | 175k | 32.33 | |
| Dyax | 1.4 | $4.4M | 116k | 37.62 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $3.7M | 221k | 16.60 | |
| Lipocine | 0.9 | $2.9M | 221k | 12.93 | |
| Accelr8 Technology | 0.8 | $2.3M | 108k | 21.49 | |
| Invuity | 0.6 | $1.8M | 203k | 8.82 | |
| Cytrx | 0.4 | $1.2M | 471k | 2.65 | |
| Biopharmx | 0.2 | $563k | 371k | 1.52 | |
| Nivalis Therapeutics | 0.1 | $232k | 30k | 7.73 | |
| Meridian Bioscience | 0.0 | $110k | 1.3k | 87.86 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $85k | 7.1k | 12.05 | |
| Nevro (NVRO) | 0.0 | $37k | 142.00 | 260.56 | |
| Berkshire Hathaway (BRK.B) | 0.0 | $7.0k | 50.00 | 140.00 | |
| United States Oil Fund | 0.0 | $7.1k | 14k | 0.51 |
